Intracerebral Hemorrhage Therapeutics (PDF)
48 DeutschlandCard Punkte
sammeln
- Lastschrift, Kreditkarte, Paypal, Rechnung
- Kostenloser tolino webreader
This book provides a framework for goal-targeted management of the adult patient with spontaneous non-traumatic intracerebral hemorrhage (ICH). Topics addressed in a comprehensive yet practical manner in the book include pre-hospital/emergency department care, early inpatient work-up, antithrombotic- and thrombolytic-related strokes, optimal blood pressure management, avoidance of medical complications, surgical interventions, outcome prognostication, recurrence prevention, rehabilitation/recovery, special situations, systems of care, and the design of clinical trials for patients with ICH. Procedures, processes, and helpful decision-making algorithms are presented with the aid of complementary illustrations that facilitate understanding of practical aspects and enable the reader to promptly retrieve relevant information. In addition, the most current evidence-based therapies for routine management of ICH patients and a glimpse of promising future treatment strategies are reviewed. Timely and consolidated, clinicians will find this to be an indispensable resource to navigating the ever-increasing pace of discovery that is transforming what we know about ICH and its treatment.
University of California
San Francisco Medical Center, San Francisco
USA
Adnan I. Qureshi, MD
Professor of Neurology, Neurosurgery and Radiology
University of Minnesota
Minneapolis, MN
USA
- 2018, 1st ed. 2018, 206 Seiten, Englisch
- Herausgegeben: Bruce Ovbiagele, Adnan I. Qureshi
- Verlag: Springer-Verlag GmbH
- ISBN-10: 3319770632
- ISBN-13: 9783319770635
- Erscheinungsdatum: 29.08.2018
Abhängig von Bildschirmgröße und eingestellter Schriftgröße kann die Seitenzahl auf Ihrem Lesegerät variieren.
- Dateiformat: PDF
- Größe: 3.63 MB
- Ohne Kopierschutz
- Vorlesefunktion
| Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
|---|
Schreiben Sie einen Kommentar zu "Intracerebral Hemorrhage Therapeutics".
Kommentar verfassen